Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, info-tech, privacy and confidentiality issues from a mainly UK and European perspective. The team is Neil J. Wilkof, Annsley Merelle Ward, Nicola Searle, Eleonora Rosati, and Merpel, with contributions from Mark Schweizer. Read, post comments and participate! E-mail the Kats here

The team is joined by Guest Kats Rosie Burbidge, Stephen Jones, Mathilde Pavis, and Eibhlin Vardy, and by InternKats Verónica Rodríguez Arguijo, Hayleigh Bosher, Tian Lu and Cecilia Sbrolli.

Monday, 16 February 2015

Another week, another Monday morning -- and another chance to catch up on whatever you missed on the IPKat's weblog last week. Here comes the 33rd weekly round-up of last week's Katposts, recorded by the sensitive pen of Katfriend par excellenceAlberto Bellan, who writes as follows:

This is the last post in this series of six on biotech,
which Suleman has kindly written for the happiness of both patent and
non-patent enthusiasts. The earlier posts can be found here (introductory), here (ethics), here (case law), here (strategies for protecting biotech
inventions) and here (financing). This post summarises the
issues of drug prices and access to medicines, which received the most comments
from readers of the previous posts.

Katfriends Elisabetta
Mina and Marina
Lanfranconi (MILA Legal) write about an intriguing
case recently decided by the District Court of Milan and concerning
unauthorised use of evocative elements of Audrey Hepburn's image in an
advertisement.

Jeremy reviews The Logic of Innovation:
Intellectual Property, and What the User Found There, from emeritus
Kat and eminent academic Johanna Gibson (Herchel Smith Professor of
Intellectual Property Law, Queen Mary University of London) and the fourth
edition of Tritton on Intellectual Property in Europe, the
standard work named after Katfriend and greatly ironic soul Guy Tritton
(Hogarth Chambers).

Katfriend Marty Schwimmer reports on Belmora LLC v
Bayer Consumer Care AG and Bayer Healthcare LLC, 1:14-cv-00847-GBL (EDVA
Feb. 6, 2015), a recent US District Court for the Eastern District of Virginia
ruling that deals with Article 6bis of the Paris Convention in the
US as it applies to Bayer’s trade mark ‘FLANAX’.

CET-J is an independent group of 15 trade mark judges
from Austria, Hungary, Germany, Netherlands, Switzerland, Turkey, France the
United Kingdom, Portugal, Italy, Germany, and OHIM. As Jeremy recounts, the
group is open both to new judges joining its meetings and sponsors.

While the copyright dispute involving Robin Thicke and
Marvin Gaye [see here and here]is entering the trial phase, Tom sinks his
paws in the world of infringement in the music industries, between occasional
similarities and copies that go beyond mere coincidence.

Merpel has it from an unimpeachable source that
earlier last week, there was an informal get-together of European Patent
Office's Administrative Council chairman. She couldn’t wait to tell the IPKat
readers what that is about.

Many decades after the publication of To Kill a
Mockingbird, Harper Lee’s lawyer said they had just found an unpublished
sequel of that classic novel, which will be launched in July 2015. Some say Ms Lee
is currently not in full control of her mind; some say the sequel is not
entirely genuine -- and these are not the only tricky issues surrounding
this tale, recounts Neil.

As President Obama announces significant investments
to ‘pioneer a new model of patient-powered research’, Biotech Kat Suleman
seizes the chance to revisit the topic of personalized medicine [on
which he previously enlightened the readership here].

IPKat Policies

This page summarises the IPKat policies on guest submissions and comments. If you have posted a comment to one of our blogposts and it hasn't appeared, it may be because it doesn't match our criteria for moderation. To learn more about our guest submissions, comments and complaints policy and the procedure for lodging a complaint click here.

Has the Kat got your tongue?

Just click the magic box below and get this page translated into a bewildering selection of languages!